Do Luxembourg Assurance Vie policies conform to US tax law and avoid PFICs?
It is now possible for a U.S. citizen to buy a Luxembourg Assurance Vie product and invest in individual stocks, which some believe avoids the PFIC problem of Assurance Vie. But it simply isn’t the case. And the problem is that Luxembourg assurance-vie contracts typically do NOT qualify under IRC §7702 for US tax treatment as « life insurance contracts. » They are almost always classified as PFICs (Passive Foreign Investment Companies) by the IRS.
Why Luxembourg AV Fails §7702
Section 7702 requires strict cash value accumulation and mortality/expense tests:
Investment-heavy: Lux AV are primarily unit-linked/unit-linked wrappers (90%+ of market) holding funds/portfolios. Cash value tests fail because premiums go directly to investments, not « insurance reserves. »
« Active insurance » requirement: US definition demands significant true insurance risk (death benefit > cash value). Lux contracts prioritize investment growth over pure insurance.
So the key idea for an insurance policy is that it has to have real « insurance benefits » and not just used as an investment vehicle or to reduce taxes. Bottom line, we would love for Luxembourg products to solve our PFIC problem, but they don’t. Investing in individual stocks within Luxembourg assurance-vie does NOT change PFIC status or enable §7702 treatment. The wrapper itself (insurance contract) determines classification, not underlying assets.